Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 5/20 | 0.40 |
| ▸ | LIPG | Q9Y5X9 | 5/20 | 0.40 |
| ▸ | EGFR | P00533 | 4/20 | 0.37 |
| ▸ | LIPE | Q05469 | 1/20 | 0.34 |
| ▸ | JAK2 | O60674 | 3/20 | 0.33 |
| ▸ | BTK | Q06187 | 3/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | HTR2B | P41595 | 1/20 | 0.31 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.30 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29795220 | 1.00 | LPL (0.40) | LPLLIPGEGFRLIPEJAK2 | |
| SCHEMBL31554791 | 0.87 | LPL (0.41) | LPLLIPGEGFRLIPEJAK2 | |
| SCHEMBL18113006 | 0.87 | LPL (0.41) | LPLLIPGEGFRLIPEJAK2 | |
| SCHEMBL897058 | 0.81 | LPL (0.50) | LPLLIPGEGFRJAK2BTK | |
| SCHEMBL29424567 | 0.81 | LPL (0.50) | LPLLIPGEGFRJAK2BTK | |
| SCHEMBL15071862 | 0.81 | TSHR (0.39) | LPLLIPGEGFRJAK2BTK | |
| SCHEMBL21042445 | 0.81 | LIPG (0.50) | LPLLIPGEGFRJAK2BTK | |
| SCHEMBL37395635 | 0.80 | LPL (0.41) | LPLLIPGEGFRJAK2BTK | |
| SCHEMBL6120636 | 0.80 | LPL (0.41) | LPLLIPGEGFRJAK2BTK | |
| SCHEMBL17491867 | 0.80 | LPL (0.53) | LPLLIPGEGFRROCK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12628546-B2 | Polymer and organic light-emitting diode using same | LG CHEM, LTD. (KR) | 2026-05-12 | — | — | US | disclosed |
| CN-116082355-B | Anthracene compound, mixture, composition and organic electronic device | 广州华睿光电材料有限公司 | 2025-05-16 | — | — | CN | disclosed |
| CN-114761462-B | Polymer and organic light emitting diode using the same | 株式会社LG化学 | 2024-02-23 | — | — | CN | disclosed |
| CN-114867703-B | Fluorene-based compound, organic light-emitting device using the same, and method for manufacturing the same | 株式会社LG化学 | 2024-01-12 | — | — | CN | disclosed |
| EP-4273146-A1 | TRICYCLIC COMPOUND AND USE THEREOF | Nanjing Zaiming Pharmaceutical Co., Ltd. (CN) | 2023-11-08 | — | — | EP | disclosed |
| CN-116082355-A | Anthracene compound, mixture, composition and organic electronic device | 广州华睿光电材料有限公司 | 2023-05-09 | — | — | CN | disclosed |
| US-20230098935-A1 | Fluorene-Based Compound, Organic Light-Emitting Device Using Same, And Manufacturing Method Therefor | LG CHEM, LTD. (KR) | 2023-03-30 | — | — | US | disclosed |
| US-20230087796-A1 | Polymer and Organic Light-Emitting Diode Using Same | LG CHEM, LTD. (KR) | 2023-03-23 | — | — | US | disclosed |
| EP-4063427-A1 | POLYMER AND ORGANIC LIGHT-EMITTING DIODE USING SAME | LG Chem, Ltd. (KR) | 2022-09-28 | — | — | EP | disclosed |
| EP-4063342-A1 | FLUORENE-BASED COMPOUND, ORGANIC LIGHT-EMITTING DEVICE USING SAME, AND MANUFACTURING METHOD THEREFOR | Lg Chem, Ltd. (KR) | 2022-09-28 | — | — | EP | disclosed |
| CN-109293656-A | Bcl-2 selective depressant and its preparation and use | 北京赛林泰医药技术有限公司 | 2019-02-01 | — | — | CN | disclosed |
| WO-2018041248-A1 | BCL-2 SELECTIVE INHIBITOR AND PREPARATION AND USE THEREOF | 北京赛林泰医药技术有限公司 | 2018-03-08 | — | — | WO | disclosed |
| US-9340529-B2 | Triazolones as fatty acid synthase inhibitors | GLAXOSMITHKLINE LLC (US) | 2016-05-17 | — | — | US | disclosed |
| US-8802864-B2 | Triazolones as fatty acid synthase inhibitors | GLAXOSMITHKLINE LLC (US) | 2014-08-12 | — | — | US | disclosed |
| US-20140100213-A1 | TRIAZOLONES AS FATTY ACID SYNTHASE INHIBITORS | GLAXOSMITHKLINE LLC (US) | 2014-04-10 | — | — | US | disclosed |
| EP-2538787-A1 | TRIAZOLONES AS FATTY ACID SYNTHASE INHIBITORS | GlaxoSmithKline LLC (US) | 2013-01-02 | — | — | EP | disclosed |
| US-20120316151-A1 | TRIAZOLONES AS FATTY ACID SYNTHASE INHIBITORS | GLAXOSMITHKLINE LLC | 2012-12-13 | — | — | US | disclosed |
| WO-2011103546-A1 | TRIAZOLONES AS FATTY ACID SYNTHASE INHIBITORS | GLAXOSMITHKLINE LLC (US) | 2011-08-25 | — | — | WO | disclosed |
| US-6969716-B2 | 5-phenyl[1,2,4]triazines as ligands for GABA-A α2/α3 receptors for treating anxiety or depression | MERCK SHARP & DOHME LTD. | 2005-11-29 | — | — | US | disclosed |
| US-20040192692-A1 | 5-Phenyl[1,2,4]triazines as ligands for GABA-A alpha2/alpha3 receptors for treating anxiety or depression | MERCK SHARP & DOHME, LTD. (GB) | 2004-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12628546-B2 | Polymer and organic light-emitting diode using same | CCNE2, CCNL2, CCNB1 | LPL 2662/4885LIPG 3605/4885EGFR 1776/4885 |
| US-20230098935-A1 | Fluorene-Based Compound, Organic Light-Emitting Device Using Same, And Manufacturing Method Therefor | AFF1, FAR1, RFT1 | LPL 2969/4885LIPG 4038/4885EGFR 1807/4885 |
| US-20140100213-A1 | TRIAZOLONES AS FATTY ACID SYNTHASE INHIBITORS | FASN, FADS1, FADS2 | LPL 270/4885LIPG 251/4885EGFR 1898/4885 |
| US-20040192692-A1 | 5-Phenyl[1,2,4]triazines as ligands for GABA-A alpha2/alpha3 receptors for treating anxiety or depression | GABRA1, GABRA5, GABRA2 | LPL 4762/4885LIPG 4876/4885EGFR 715/4885 |
| US-20120316151-A1 | TRIAZOLONES AS FATTY ACID SYNTHASE INHIBITORS | FASN, FADS1, FADS2 | LPL 340/4885LIPG 247/4885EGFR 1979/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.